160 related articles for article (PubMed ID: 29653132)
1. Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system.
Jiang W; Muhammad F; Ma P; Liu X; Long G
Antiviral Res; 2018 Jun; 154():51-57. PubMed ID: 29653132
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.
Yang L; Kiyohara T; Kanda T; Imazeki F; Fujiwara K; Gauss-Müller V; Ishii K; Wakita T; Yokosuka O
Virol J; 2010 Sep; 7():212. PubMed ID: 20815893
[TBL] [Abstract][Full Text] [Related]
3. The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells.
Jiang X; Kanda T; Nakamoto S; Saito K; Nakamura M; Wu S; Haga Y; Sasaki R; Sakamoto N; Shirasawa H; Okamoto H; Yokosuka O
Biochem Biophys Res Commun; 2015 Mar; 458(4):908-12. PubMed ID: 25704089
[TBL] [Abstract][Full Text] [Related]
4. Rapid and convenient assays to assess potential inhibitory activity on in vitro hepatitis A replication.
Debing Y; Kaplan GG; Neyts J; Jochmans D
Antiviral Res; 2013 May; 98(2):325-31. PubMed ID: 23528258
[TBL] [Abstract][Full Text] [Related]
5. Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication.
Esser-Nobis K; Harak C; Schult P; Kusov Y; Lohmann V
Hepatology; 2015 Aug; 62(2):397-408. PubMed ID: 25866017
[TBL] [Abstract][Full Text] [Related]
6. Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.
Sasaki-Tanaka R; Shibata T; Moriyama M; Okamoto H; Kogure H; Kanda T
J Virol; 2022 Sep; 96(18):e0064622. PubMed ID: 36040176
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology and inhibitors of hepatitis A virus.
Debing Y; Neyts J; Thibaut HJ
Med Res Rev; 2014 Sep; 34(5):895-917. PubMed ID: 23722879
[TBL] [Abstract][Full Text] [Related]
8. Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus.
Win NN; Kanda T; Ogawa M; Nakamoto S; Haga Y; Sasaki R; Nakamura M; Wu S; Matsumoto N; Matsuoka S; Kato N; Shirasawa H; Yokosuka O; Okamoto H; Moriyama M
Int J Med Sci; 2019; 16(10):1366-1370. PubMed ID: 31692913
[TBL] [Abstract][Full Text] [Related]
9. The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis.
Li Y; Misumi I; Shiota T; Sun L; Lenarcic EM; Kim H; Shirasaki T; Hertel-Wulff A; Tibbs T; Mitchell JE; McKnight KL; Cameron CE; Moorman NJ; McGivern DR; Cullen JM; Whitmire JK; Lemon SM
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2204511119. PubMed ID: 35867748
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro.
Dragoni F; Boccuto A; Picarazzi F; Giannini A; Giammarino F; Saladini F; Mori M; Mastrangelo E; Zazzi M; Vicenti I
Antiviral Res; 2020 Mar; 175():104708. PubMed ID: 31931104
[TBL] [Abstract][Full Text] [Related]
11. Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.
Dao Thi VL; Debing Y; Wu X; Rice CM; Neyts J; Moradpour D; Gouttenoire J
Gastroenterology; 2016 Jan; 150(1):82-85.e4. PubMed ID: 26408347
[TBL] [Abstract][Full Text] [Related]
12. Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.
Kanda T; Sasaki R; Masuzaki R; Matsumoto N; Ogawa M; Moriyama M
Viruses; 2020 May; 12(5):. PubMed ID: 32408660
[TBL] [Abstract][Full Text] [Related]
13. Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.
Sasaki-Tanaka R; Masuzaki R; Okamoto H; Shibata T; Moriyama M; Kogure H; Kanda T
J Virol; 2023 Feb; 97(2):e0198722. PubMed ID: 36728416
[TBL] [Abstract][Full Text] [Related]
14. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure.
Mendes ÉA; Pilger DRB; Santos Nastri ACS; Malta FM; Pascoalino BDS; Carneiro D'Albuquerque LA; Balan A; Freitas LHG; Durigon EL; Carrilho FJ; Rebello Pinho JR
Ann Hepatol; 2019; 18(6):816-824. PubMed ID: 31594756
[TBL] [Abstract][Full Text] [Related]
15. Interference of hepatitis A virus replication by small interfering RNAs.
Kanda T; Kusov Y; Yokosuka O; Gauss-Müller V
Biochem Biophys Res Commun; 2004 May; 318(2):341-5. PubMed ID: 15120607
[TBL] [Abstract][Full Text] [Related]
16. Free fatty acids or high-concentration glucose enhances hepatitis A virus replication in association with a reduction in glucose-regulated protein 78 expression.
Nwe Win N; Kanda T; Nakamura M; Nakamoto S; Okamoto H; Yokosuka O; Shirasawa H
Biochem Biophys Res Commun; 2017 Jan; 483(1):694-699. PubMed ID: 27986562
[TBL] [Abstract][Full Text] [Related]
17. Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.
Wang W; Hakim MS; Nair VP; de Ruiter PE; Huang F; Sprengers D; Van Der Laan LJ; Peppelenbosch MP; Surjit M; Pan Q
Gastroenterology; 2016 Dec; 151(6):1251-1253. PubMed ID: 27815000
[No Abstract] [Full Text] [Related]
18. The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity.
Kanda T; Sasaki R; Nakamoto S; Haga Y; Nakamura M; Shirasawa H; Okamoto H; Yokosuka O
Biochem Biophys Res Commun; 2015 Oct; 466(3):567-71. PubMed ID: 26388050
[TBL] [Abstract][Full Text] [Related]
19. Additive Effects of Zinc Chloride on the Suppression of Hepatitis A Virus Replication by Interferon in Human Hepatoma Huh7 Cells.
Kanda T; Sasaki R; Masuzaki R; Takahashi H; Fujisawa M; Matsumoto N; Okamoto H; Moriyama M
In Vivo; 2020; 34(6):3301-3308. PubMed ID: 33144437
[TBL] [Abstract][Full Text] [Related]
20. Cell-line dependent antiviral activity of sofosbuvir against Zika virus.
Mumtaz N; Jimmerson LC; Bushman LR; Kiser JJ; Aron G; Reusken CBEM; Koopmans MPG; van Kampen JJA
Antiviral Res; 2017 Oct; 146():161-163. PubMed ID: 28912011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
